Carotid artery surgery vs. stent: a cardiovascular perspective

Imad A Alhaddad1

  • 1Cardiovascular Division, Department of Internal Medicine, Johns Hopkins Hospital, Johns Hopkins University, Baltimore, Maryland, USA. ialhadd1@jhmi.edu

Insights

Carotid artery stenosis increases stroke risk. Carotid endarterectomy (CEA) and carotid artery stenting (CS) are revascularization options, with CS emerging as a less invasive alternative for high-risk patients.

Area of Science:

  • Neurology
  • Vascular Surgery
  • Cardiology

Background:

  • Stroke is a leading cause of death and disability.
  • Carotid artery stenosis is a significant risk factor for ischemic stroke.
  • Accurate measurement of stenosis is crucial for treatment decisions.

Purpose of the Study:

  • To review methods for measuring carotid artery stenosis.
  • To discuss the role of revascularization in preventing stroke.
  • To compare carotid endarterectomy (CEA) and carotid artery stenting (CS).

Main Methods:

  • Review of randomized clinical trials comparing CEA and CS.
  • Analysis of perioperative complications associated with CEA.
  • Evaluation of CS as an alternative for high-surgical-risk patients.

Main Results:

  • CEA is a common procedure with demonstrated benefits but carries risks.
  • CEA complications include stroke, anesthesia issues, and cardiac/nerve injury.
  • CS with embolic protection is a viable alternative for high-risk and surgically inaccessible stenoses.

Conclusions:

  • CEA is beneficial for selected patients with carotid artery stenosis.
  • CS offers a less invasive option, particularly for high-risk individuals.
  • Further research is needed to define the role of CS in low-risk patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...